BVF INVESTMENTS LLC's Net Worth

$3.75 Billion

Estimate Recalculated Feb 29, 2024 07:12PM EST

Who is BVF INVESTMENTS LLC?

BVF INVESTMENTS LLC has an estimated net worth of $3.75 Billion. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, Capstone Therapeutics Corp., ChemoCentryx, Inc., DYNAVAX TECHNOLOGIES CORP, REPLIGEN CORP, KENT INTERNATIONAL HOLDINGS INC, NEUROCRINE BIOSCIENCES INC, LIGAND PHARMACEUTICALS INC, RIGEL PHARMACEUTICALS INC, CURIS INC, PALATIN TECHNOLOGIES INC, MEDICINOVA INC, CATALYST BIOSCIENCES, INC., ADVANCED MAGNETICS INC, NPS PHARMACEUTICALS INC, ICAGEN INC, ADOLOR CORP, ZONAGEN INC, COMBINATORX, INC, SUPERGEN INC, ARRAY BIOPHARMA INC, ARQULE INC, AEOLUS PHARMACEUTICALS, INC., INHIBITEX, INC., NEUROBIOLOGICAL TECHNOLOGIES INC /CA/, Celera CORP, FACET BIOTECH CORP, PHARMACOPEIA INC, AVIGEN INC \DE, SGX PHARMACEUTICALS, INC., VIACELL INC, NEUROGEN CORP, GENAERA CORP, AEROGEN INC, CORVAS INTERNATIONAL INC, BIOCRYST PHARMACEUTICALS INC, and APPLIED MOLECULAR EVOLUTION INC.

SEC CIK

BVF INVESTMENTS LLC's CIK is 0001132245

Past Insider Trading and Trends

2008 was BVF INVESTMENTS LLC's most active year for acquiring shares with 351 total transactions. BVF INVESTMENTS LLC's most active month to acquire stocks was the month of October. 2009 was BVF INVESTMENTS LLC's most active year for disposing of shares, totalling 86 transactions. BVF INVESTMENTS LLC's most active month to dispose stocks was the month of June. 2011 saw BVF INVESTMENTS LLC paying a total of $81,370,335.37 for 12,332,928 shares, this is the most they've acquired in one year. In 2007 BVF INVESTMENTS LLC cashed out on 7,305,900 shares for a total of $52,967,775.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARENA PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.32%
-828.09K
$5.10
-$4,219,175.99
5.89M
Jul 7 - Jul 8
Form 4
-3.35%
-95.00K
$5.42
-$514,900.00
2.74M
Jul 1
Form 4
-2.44%
-71.00K
$5.31
-$376,797.00
2.83M
Jun 29
Form 4
-0.92%
-54.00K
$5.36
-$287,009.90
5.82M
Jun 28
Form 4
-0.20%
-6.00K
$5.52
-$33,114.00
2.96M
Jun 18
Form 4
-3.39%
-104.00K
$5.40
-$561,600.00
2.97M
Jun 16
Form 4
-1.64%
-144.50K
$6.00
-$867,000.00
8.67M
Jan 20 - Jan 21
Form 4
-2.87%
-95.00K
$6.05
-$574,750.00
3.21M
Jan 14
Form 4
-0.72%
-24.00K
$6.30
-$151,200.00
3.31M
Jan 9
Form 4
-26.26%
-1.19M
$6.20
-$7,359,400.00
3.33M
Dec 31
Form 4
-39.17%
-2.91M
$7.69
-$22,385,590.00
4.52M
Oct 17
No matching records found

Capstone Therapeutics Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-65.68%
-4.34M
$0.06
-$260,495.16
2.27M
Jul 14
Form 4
-13.37%
-616.56K
$0.30
-$184,968.90
3.99M
Jul 1
Form 4
+4.53%
312.9K
$0.26
$81,041.10
7.23M
Sep 6
Form 4
+0.44%
78.9K
$0.26
$20,514.00
18.2M
Aug 18 - Aug 22
Form 4
+8.71%
954.25K
$0.25
$238,562.50
11.91M
Jul 28 - Jul 29
Form 4
+0.37%
18.4K
$0.25
$4,600.00
5.05M
Jul 26
Form 4
+5.28%
252.6K
$0.25
$63,099.48
5.03M
Jul 20
Form 4
+4.70%
358.6K
$0.25
$89,344.99
7.99M
Jul 14 - Jul 18
Form 4
+0.28%
9K
$0.25
$2,250.00
3.19M
Jul 11
Form 4
+0.09%
4.7K
$0.25
$1,171.72
5.24M
Jun 30
Form 4
+1.95%
100.05K
$0.25
$24,990.49
5.24M
Jun 27 - Jun 29
Form 4
+30.04%
1.19M
$0.62
$736,473.60
5.14M
Oct 10 - Oct 14
Form 3
0
0
No matching records found

ChemoCentryx, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.74M
$7.00
-$2,518,400.30
0
Nov 3 - Nov 5
Form 4
-1.79%
-50.00K
$6.97
-$348,515.00
2.74M
Nov 2
Form 4
-25.48%
-955.70K
$9.00
-$8,601,621.87
2.79M
Jun 9 - Jun 10
Form 4
+2.91%
189.8K
$5.01
$951,153.58
6.7M
Dec 3 - Dec 5
Form 4
+1.84%
136.07K
$4.84
$669,798.66
7.54M
Nov 4 - Nov 6
Form 4
+3.88%
336.23K
$4.98
$1,676,807.60
9M
Oct 30 - Nov 1
Form 4
+31.20%
1.29M
$5.31
$6,886,910.63
5.42M
Oct 8 - Oct 9
Form 4
+8.09%
109.42K
$5.49
$601,202.84
1.46M
Oct 3
Form 4
+13.73%
325.63K
$6.02
$1,936,125.49
2.7M
Sep 11 - Sep 13
Form 4/A
+1.08%
40K
$12.00
$479,828.00
3.75M
Nov 6
Form 4
+1.08%
40K
$12.00
$479,828.00
3.75M
Nov 6
Form 3
0
0
No matching records found

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.91

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.07%
-1.21M
$2.76
-$3,350,988.25
4.28M
Sep 10
Form 4
-6.78%
-399.50K
$2.00
-$800,726.50
5.49M
Aug 5 - Aug 6
Form 4
-0.26%
-15.60K
$1.85
-$28,906.80
5.89M
Jul 30
Form 4
-6.46%
-407.60K
$1.94
-$789,228.94
5.91M
Jul 27 - Jul 29
Form 4
-22.16%
-1.80M
$1.90
-$3,412,690.10
6.31M
Jun 3 - Jun 4
Form 4
-0.27%
-22.00K
$1.30
-$28,600.00
8.11M
Apr 27
Form 3
0
0
No matching records found

REPLIGEN CORP (RGEN) Snapshot price: $201.75

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.04%
-451.80K
$5.52
-$2,491,977.56
2.77M
Jul 6 - Jul 7
Form 3
0
0
Form 4
0
0
No matching records found